Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study

OBJECTIVE: To determine the efficacy and safety of deutetrabenazine as a treatment for tardive dyskinesia (TD). METHODS: One hundred seventeen patients with moderate to severe TD received deutetrabenazine or placebo in this randomized, double-blind, multicenter trial. Eligibility criteria included a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez, Hubert H., Factor, Stewart A., Hauser, Robert A., Jimenez-Shahed, Joohi, Ondo, William G., Jarskog, L. Fredrik, Meltzer, Herbert Y., Woods, Scott W., Bega, Danny, LeDoux, Mark S., Shprecher, David R., Davis, Charles, Davis, Mat D., Stamler, David, Anderson, Karen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440239/
https://www.ncbi.nlm.nih.gov/pubmed/28446646
http://dx.doi.org/10.1212/WNL.0000000000003960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440239/
https://www.ncbi.nlm.nih.gov/pubmed/28446646
http://dx.doi.org/10.1212/WNL.0000000000003960

Ejemplares similares